C44H50Cl2N6Pd, monoclinic, P121/c1 (no. 14), a = 8.9983(2) Å, b = 12.9387(3) Å, c = 18.6706(4) Å, β = 101.365(2)°, V = 2131.1 Å3, Z = 2, Rgt(F) = 0.027, wRref(F2) = 0.072, T = 233 K
[[abstract]]In the structure of the title compound, [PdCl2(C5H10N2)2], at 150 K, the Pd atom is situ...
C40H31Cl2N3Pd, orthorhombic, Pnma (no. 62), a = 16.7821(7), b = 14.1436(8), c = 11.1431(5) Å, V = 3...
The molecular structures of the chiral title compounds, [Pd(C19H28N2)2I2], (I), and [Pd(C19H28N2)Cl2...
C25H31Cl2N3OPd, orthorhombic, Pbca (no. 61), a = 9.4083(4) Å, b = 17.1334(8) Å, c = 31.9251(14) Å, V...
C30H26ClN2PPd, triclinic, P1̄ (no. 2), a = 9.1278(5) Å, b = 9.5892(7) Å, c = 15.5255(10) Å, α = 79.8...
C28H27Cl2N3Pd, monoclinic (no. 15), C2/c, a = 24.7394(17) Å, b = 15.9451(11) Å, c = 27.4301(19) ...
C29H36Cl8N2Pd, orthorhombic, P212121 (no. 19), a = 16.5460(8) Å, b = 17.995(1) Å, c = 11.817(1) Å, V...
The title compound 1 has been synthesized and its structure has been determined by singlecrystal X-r...
C34H39Cl2N3O2Pd, triclinic, P1̅, a = 10.3988(8) Å, b = 12.1983(10) Å, c = 12.9114(10) Å, α = 85.0...
C22H16Cl2N2Pd2, monoclinic, P21/c (no. 14), a = 7.2249(6) Å, b = 17.0538(14) Å, c = 8.4291(7) Å, β =...
International audienceC40H31Cl2N3Pd, orthorhombic, Pnma (no. 62), a = 16.7821(7), b = 14.1436(8), c ...
Trcitts-Bis[1,3-bis(2,4-dimethylphenylimidazolidin-2-ylidene)]dichloropalladium(II), 4, was prepared...
Trcitts-Bis[1,3-bis(2,4-dimethylphenylimidazolidin-2-ylidene)]dichloropalladium(II), 4, was prepared...
WOS: 000255750500009Trcitts-Bis[1,3-bis(2,4-dimethylphenylimidazolidin-2-ylidene)]dichloropalladium(...
International audienceC52H39Cl2N3Pd, tetragonal, I4(1)/a (no. 88), a = 40.0310(3) angstrom, c = 10.4...
[[abstract]]In the structure of the title compound, [PdCl2(C5H10N2)2], at 150 K, the Pd atom is situ...
C40H31Cl2N3Pd, orthorhombic, Pnma (no. 62), a = 16.7821(7), b = 14.1436(8), c = 11.1431(5) Å, V = 3...
The molecular structures of the chiral title compounds, [Pd(C19H28N2)2I2], (I), and [Pd(C19H28N2)Cl2...
C25H31Cl2N3OPd, orthorhombic, Pbca (no. 61), a = 9.4083(4) Å, b = 17.1334(8) Å, c = 31.9251(14) Å, V...
C30H26ClN2PPd, triclinic, P1̄ (no. 2), a = 9.1278(5) Å, b = 9.5892(7) Å, c = 15.5255(10) Å, α = 79.8...
C28H27Cl2N3Pd, monoclinic (no. 15), C2/c, a = 24.7394(17) Å, b = 15.9451(11) Å, c = 27.4301(19) ...
C29H36Cl8N2Pd, orthorhombic, P212121 (no. 19), a = 16.5460(8) Å, b = 17.995(1) Å, c = 11.817(1) Å, V...
The title compound 1 has been synthesized and its structure has been determined by singlecrystal X-r...
C34H39Cl2N3O2Pd, triclinic, P1̅, a = 10.3988(8) Å, b = 12.1983(10) Å, c = 12.9114(10) Å, α = 85.0...
C22H16Cl2N2Pd2, monoclinic, P21/c (no. 14), a = 7.2249(6) Å, b = 17.0538(14) Å, c = 8.4291(7) Å, β =...
International audienceC40H31Cl2N3Pd, orthorhombic, Pnma (no. 62), a = 16.7821(7), b = 14.1436(8), c ...
Trcitts-Bis[1,3-bis(2,4-dimethylphenylimidazolidin-2-ylidene)]dichloropalladium(II), 4, was prepared...
Trcitts-Bis[1,3-bis(2,4-dimethylphenylimidazolidin-2-ylidene)]dichloropalladium(II), 4, was prepared...
WOS: 000255750500009Trcitts-Bis[1,3-bis(2,4-dimethylphenylimidazolidin-2-ylidene)]dichloropalladium(...
International audienceC52H39Cl2N3Pd, tetragonal, I4(1)/a (no. 88), a = 40.0310(3) angstrom, c = 10.4...
[[abstract]]In the structure of the title compound, [PdCl2(C5H10N2)2], at 150 K, the Pd atom is situ...
C40H31Cl2N3Pd, orthorhombic, Pnma (no. 62), a = 16.7821(7), b = 14.1436(8), c = 11.1431(5) Å, V = 3...
The molecular structures of the chiral title compounds, [Pd(C19H28N2)2I2], (I), and [Pd(C19H28N2)Cl2...
DOI
Add to ORKG